AbbVie announced that the FDA has approved a new packaging option for AndroGel (testosterone gel) 1.62%. Besides the previously approved metered-dose pump packaging, Androgel 1.62% will also be ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
Mumbai, Baltimore, April 11, 2019: Pharma major Lupin Limited (Lupin) announced that it has received approval for its Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), from the United States ...
ALLEGAN -- Perrigo Co. (Nasdaq: PRGO) announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for testosterone gel 1.62 percent and that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback